Mel de Villiers, associate professor in the Pharmaceutical Sciences Division, has been selected to serve on the Editorial Board of Current Drug Discovery Technologies.
He was also recently appointed as an Associate Editor for the Journal of Biomedical Nanotechnology. Research from the de Villiers’ lab describing the effect of polyamidoamine dendrimers on the cytotoxicity of paclitaxel in prostate cancer cells is featured on the cover of the March 2008 edition of the journal.